InMode to Participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference

Rhea-AI Summary

InMode (Nasdaq: INMD) will participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference in Snowbird, UT. Yair Malca, Chief Financial Officer, will host investor meetings on Wednesday, February 11, 2026. Interested investors should contact their BTIG salesperson to schedule a meeting and may visit InMode's investor relations site for event details.

Key Figures

Conference edition: 13th annual Conference date: February 11, 2026

2 metrics

Conference edition 13th annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference

Conference date February 11, 2026 BTIG conference investor meetings in Snowbird, UT

Market Reality Check

Price: $16.62 Vol: Volume 1,726,670 vs 1,078...

high vol

$16.62 Last Close

Volume Volume 1,726,670 vs 1,078,700 20-day average (relative volume 1.6x). high

Technical Price 16.62 is trading above 200-day MA at 14.62, pre-conference announcement.

Peers on Argus

INMD gained 5.79% pre-news while close peers showed mixed, mostly modest moves (...

INMD gained 5.79% pre-news while close peers showed mixed, mostly modest moves (e.g., IRMD +1.14%, IART +1%, TNDM +1.01%, BBNX -0.07%, SSII -8.5%), suggesting stock-specific strength rather than a broad Medical Devices move.

Historical Context

5 past events · Latest: Jan 28 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Jan 28	Partial buyout offer	Positive	-0.8%	51% acquisition proposal at <b>$18</b> per share premium to prior price.
Jan 08	Guidance & call date	Negative	-8.8%	Preliminary Q4/FY2025 results and FY2026 revenue guidance announcement.
Nov 05	Q3 earnings	Neutral	-0.7%	Q3 2025 results with lower revenue year over year and reaffirmed guidance.
Nov 03	Management change	Positive	-0.5%	Appointment of Michael Dennison as President of North America.
Oct 30	Investor conferences	Neutral	-1.4%	Planned participation in three November 2025 investor conferences.

Pattern Detected

Recent history shows multiple positive or neutral corporate updates followed by negative 1‑day reactions, indicating a pattern of cautious trading around news.

Recent Company History

Over the last few months, InMode has reported Q3 2025 results with revenue of $93.2M and 78% gross margin, reaffirming 2025 guidance. It issued preliminary Q4 and FY2025 revenue ranges and FY2026 guidance and saw the stock drop 8.82% the next day. A board-level offer at $18.00 per share for 51% of the company and a North America leadership appointment also drew small negative reactions. Participation in multiple investor conferences in November 2025 likewise coincided with a modest decline, framing today’s conference notice against a backdrop of guarded price responses.

Market Pulse Summary

This announcement highlights InMode’s continued engagement with the investment community via the BTI...

Analysis

This announcement highlights InMode’s continued engagement with the investment community via the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference on February 11, 2026. It follows recent financial updates and strategic discussions, including prior guidance and an offer proposal. Investors may focus on how messaging at this conference complements earlier disclosures and any future filings, especially given the company’s history of notable news around earnings and governance events.

AI-generated analysis. Not financial advice.

YOKNEAM, Israel, Feb. 3, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer will host investor meetings at the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference in Snowbird, UT on Wednesday, February 11, 2026.

Interested investors are welcome to contact their BTIG salesperson and schedule a meeting.

For more information about the event, visit InMode's investor relations site here.

About InMode

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.

Investor Relations Contact:

Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com 

Photo - https://mma.prnewswire.com/media/1064477/5747577/InMode_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/inmode-to-participate-in-the-13th-annual-btig-medtech-digital-health-life-sciences--diagnostics-tools-conference-302676552.html

SOURCE InMode Ltd.

FAQ

When will InMode (INMD) hold investor meetings at the BTIG conference?

InMode will hold investor meetings on Wednesday, February 11, 2026 in Snowbird, UT with its CFO hosting. According to InMode, investors should contact their BTIG salesperson to schedule meetings and visit the company's investor relations site for event details.

Who from InMode (INMD) will represent the company at the BTIG MedTech conference?

Yair Malca, InMode's Chief Financial Officer, will represent the company and host investor meetings at the conference. According to InMode, interested investors may arrange one-on-one meetings through their BTIG salesperson and check the investor relations site for more information.

How can investors schedule a meeting with InMode (INMD) at the February 11, 2026 conference?

Investors should contact their BTIG salesperson to schedule meetings with InMode's CFO on February 11, 2026. According to InMode, the company asks investors to coordinate through BTIG and refers them to the investor relations site for additional event information.

Where is the 13th Annual BTIG MedTech conference that InMode (INMD) will attend?

The conference takes place in Snowbird, Utah, and InMode's meetings are scheduled for February 11, 2026. According to InMode, attendees and investors should use BTIG contacts to arrange meetings and consult the investor relations site for specifics.

Will InMode (INMD) provide a public webcast or presentation at the BTIG conference?

The announcement lists investor meetings but does not mention a public webcast or presentation at the conference. According to InMode, investors seeking more information should contact BTIG salespeople and consult the company's investor relations site for any updates.

What should shareholders expect from InMode's (INMD) participation in the BTIG MedTech conference?

Shareholders can expect investor meetings led by the CFO on February 11, 2026 in Snowbird, UT rather than a public corporate presentation. According to InMode, scheduling is managed through BTIG and event details are posted on the investor relations site.